Marco Niemann

Managing Director | CFO at Rottendorf Pharma

Marco Niemann has a diverse work experience in finance and management roles. Marco is currently the Managing Director and CFO at Rottendorf Pharma since August 2022. Prior to this, they worked as the Chief Financial Officer at ProMinent Group from April 2022 to August 2022. From 2019 to 2022, they served as an Advisory Board Member at IDT Biologika. Previously, they held the position of Chief Financial Officer and Prokurist at KLOCKE Holding GmbH from 2015 to 2022. Marco also has experience as a Managing Director and Kaufmännischer Leiter at Weimer Pharma GmbH from 2011 to 2014. Marco started their career at Körber AG in the field of Corporate Controlling and Corporate Finance from 2004 to 2010. Before that, they worked as a Wirtschaftsprüfungsassistent at Esche Schümann Commichau from 2000 to 2004. Prior to their professional career, Marco Niemann also played as a semi-pro football player for FC St. Pauli von 1910 e.V. and VfL 93 Hamburg e.V. from 1996 to 2001.

Marco Niemann attended the University of Münster from 2014 to 2015, where they pursued an Executive Master of Business Administration with a focus in Accounting, Controlling, and Steuern (German for taxes).

Location

Ennigerloh, Germany

Links

Previous companies


Org chart


Teams


Offices


Rottendorf Pharma

1 followers

A first-class contract development and manufacturing organization (CDMO), Rottendorf Pharma has been manufacturing, packaging, developing formulations and analytical methods for solid oral dosage forms for the global pharmaceutical industry for more than 85 years. The company produces more than 600 originator and generic drug products annually for big, small, virtual, and global pharmaceutical and biotechnology companies. Rottendorf Pharma operates by the philosophy of Total Process Ownership (TPO) and Total Technological Mastering (TTM), in which we work as an extension of clients'​ organizations. Therefore leveraging our expertise to optimize solid dosage form production for our customers'​ benefit. Rottendorf Pharma has neither their own product brands in the market nor holds any product licenses, and therefore is never in competition with their clients.


Employees

501-1,000

Links